2016
DOI: 10.1111/eve.12624
|View full text |Cite
|
Sign up to set email alerts
|

Review of glucocorticoid therapy in horses. Part 2: Clinical use of systemic glucocorticoids in horses

Abstract: Summary This article is the second in a review series about the use of glucocorticoids to treat medical and musculoskeletal conditions in horses. This segment in the series summarises reported dosages, methods of administration and the efficacy of glucocorticoids for various systemic diseases in equids. The most common use of systemic glucocorticoids reported in the literature for management and treatment of alterations of the respiratory, integumentary, immune and neurological systems are included.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 95 publications
0
9
0
Order By: Relevance
“…oxytetracycline) towards Clostridial spp . Furthermore, the use of bacteriostatic antimicrobials in conjunction with corticosteroids is, in the authors' opinion, counter‐intuitive given the potential immunosuppressive effects of the corticosteroids (Leclere, 2017; Mora Pereira et al., 2018) potentially reducing their efficacy and thus propagating antimicrobial resistance. This particular interaction is not well documented in the literature and further work is needed to confirm or refute this hypothesis.…”
Section: Discussionmentioning
confidence: 99%
“…oxytetracycline) towards Clostridial spp . Furthermore, the use of bacteriostatic antimicrobials in conjunction with corticosteroids is, in the authors' opinion, counter‐intuitive given the potential immunosuppressive effects of the corticosteroids (Leclere, 2017; Mora Pereira et al., 2018) potentially reducing their efficacy and thus propagating antimicrobial resistance. This particular interaction is not well documented in the literature and further work is needed to confirm or refute this hypothesis.…”
Section: Discussionmentioning
confidence: 99%
“…There are limited controlled studies evaluating the safety and dosing of glucocorticoids for hypersensitivity disorders in horses. Review articles regarding the function, pharmacodynamics, pharmacokinetics, indications for use and adverse effects associated with glucocorticoids are available 208,209 …”
Section: Atopic Dermatitismentioning
confidence: 99%
“…Review articles regarding the function, pharmacodynamics, pharmacokinetics, indications for use and adverse effects associated with glucocorticoids are available. 208,209 Most veterinarians rely on using two systemic glucocorticoids in practice: prednisolone and dexamethasone. Prednisone is not as effective in the horse as prednisolone, owing to poor absorption, rapid excretion and failure of hepatic conversion of prednisone to prednisolone.…”
Section: Treatmentmentioning
confidence: 99%
“…Corticosteroids inhibit the inflammatory response which is a key factor preventing the development of irreversible fibrotic damage of the lung (Pereira et al, 2016) but they can be potentially associated with multiple side effects such as worsening of viral infection, hypothalamic-pituitary-adrenal axis suppression, hyperglycaemia, polyuria and polydipsia and increased susceptibility to infections and laminitis (Leclere, 2017). This report describes the clinical presentation, diagnostic evaluation, and follow-up of a horse diagnosed with EMPF associated with EHV-5 infection and treated with systemic corticosteroids, which developed unexpected complications, including bacterial dermatitis, liver damage and acute pleural effusion.…”
Section: Introductionmentioning
confidence: 99%